Perioperative Levels of Tumor Necrosis Factor-α Correlate With Outcomes in Children and Adults With Tetralogy of Fallot Undergoing Corrective Surgery

World Journal for Pediatric and Congenital Heart Surgery

Volumn 5, Issue 1, 2014, Pages 38-46

  Sethi, Brijindera Singh ^a   Kapoor, Poonam Malhotra ^a   Chauhan, Sandeep ^a   Chowdhury, Ujjwal K ^a   Kiran, Usha ^a   Choudhury, Minati ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

cardiopulmonary bypass; congenital heart disease; cytokines; inflammatory response; outcomes

Indexed keywords

CARDIOPULMONARY BYPASS; CONGENITAL HEART DISEASE; CYTOKINES; INFLAMMATORY RESPONSE; OUTCOMES;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CARDIAC SURGICAL PROCEDURES; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INFANT; MALE; PERIOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SURGICAL PROCEDURES, ELECTIVE; TETRALOGY OF FALLOT; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CHILD; CONTROLLED STUDY; CYANOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FALLOT TETRALOGY; FEMALE; HUMAN; HYPOXEMIA; INFANT; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL STATUS; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84907608820     PISSN: 21501351     EISSN: 21500136     Source Type: Journal    
DOI: 10.1177/2150135113507290     Document Type: Article

References (35)

1. Strieter RM, Kunkel SL, Bone RC. Role of tumor necrosis factor alpha in disease states and inflammation. Crit Care Med. 1993; 21(10 suppl):S447–S463.
2. Casey WF, Hauser GJ, Hannallah RS, Midgley FM, Khan WN. Circulating endotoxin and tumor necrosis factor during pediatric cardiac surgery. Crit Care Med. 1992; 20(8):1090–1096.
3. Wan S, LeClerc JL, Vincent JL. Cytokine responses to cardiopulmonary bypass: lessons learned from cardiac transplantation. Ann Thorac Surg. 1997; 63(1):269–276.
4. Seghaye MC, Duchateau J, Bruniaux J, et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. J Thorac Cardiovasc Surg. 1996; 111(3):545–553.
5. Madhok A B, Ojamaa K, Haridas V, Parnell VA, Pahwa S, Chowdhury D. Cytokine response in children undergoing surgery for congenital heart disease. Pediatr Cardiol. 2006; 27(4):408–413.
6. Allan CK, Newburger JW, McGrath E, et al. The relationship between inflammatory activation and clinical outcome after infant cardiopulmonary bypass. Anesth Analg. 2010; 111(5):1244–1251.
7. Markewitz A, Faist E, Lang S, Endres S, Hultner L, Reichart B. Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg. 1993; 55(2):389–394.
8. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth. 1993; 40(11):1016–1021.
9. Sason-Ton Y, Abraham RB, Lotan D, et al. Tumor necrosis factor and clinical and metabolic courses after cardiac surgery in children. J Thorac Cardiovasc Surg. 2002; 124(5):991–998.
10. Teoh KH, Mickle DAG, Weisel RD, Li R, Tumiati L, Coles JG. Effect of oxygen tension and cardiovascular operations on the myocardial antioxidant enzyme activities in patients with tetralogy of Fallot and aorta-coronary bypass. J Thorac Cardiovasc Surg. 1992; 104(1):159–164.
11. Del Nido PJ, Mickle DAG, Wilson G, Benson LN, Coles JG, Trusler GA. Evidence of myocardial free radical injury during elective repair of of tetralogy of Fallot. Circulation. 1987; 76(5 pt 2):174–179.
12. Qing M, Schumacher K, Heise R, et al. Intramyocardial synthesis of pro- and antiinflammatory cytokines in infants with congenital cardiac defects. J Am Coll Cardiol. 2003; 41(12):2266–2274.
13. Hövels-Gürich HH, Schumacher K, Vazquez-Jimenez JF, et al. Cytokine balance in infants undergoing cardiac operation. Ann Thorac Surg. 2002; 73(2):601–608.
14. Sharma R, Bolger A P, Li W, et al. Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congenital heart disease. Am J Cardiol. 2003; 92(2):188–193.
15. Kapadia SR, Oral H, Lee J, Nakano M, Taffet GE, Mann DL. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium. Circ Res. 1997; 81(2):187–195.
16. Naldini A, Carraro F, Silvestri S, Bocci V. Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells. J Cell Physiol. 1997; 173(3):335–342.
17. Menon G, Poskitt EM. Why does congenital heart disease cause failure to thrive? Arch Dis Child. 1985; 60(12):1134–1139.
18. Yilmaz E, Ustundag B, Sen Y, Akarsu S, Kurt AN, Dogan Y. The levels of Ghrelin, TNF-alpha, and IL-6 in children with cyanotic and acyanotic congenital heart disease. Mediat Inflamm. 2007;2007: 32403.
19. WHO child growth standards based on length/height, weight and age. Acta Paediatr Suppl. 2006; 450: 76–85.
20. Beutler B, Cerami A. Cachectin and tumor necrosis factor are two sides of the same biological coin. Nature. 1986; 320(6063):584–588.
21. Vaisman N, Hahn T. Tumor necrosis factor alpha and anorexia. cause or effect? Metabolism. 1991; 40(7):720–723.
22. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumor necrosis factor in “cachectic” patients with severe chronic heart failure. Br Heart J. 1991; 66(5):356–358.
23. Ghorbel M, Cherif M, Jenkins E, et al. Transcriptomic analysis of patients with tetralogy of Fallot reveals the effect of chronic hypoxia on myocardial gene expression. J Thorac Cardiovasc Surg. 2010; 140(2):337–345.
24. Aguilera A, Codoceo R, Selgas R, et al. Anorexigen (TNF-alpha, cholecystokinin) and orexigen (neuropeptide Y) plasma levels in peritoneal dialysis (PD) patients: their relationship with nutritional parameters. Nephrol Dial Transplant. 1998; 13(6):1476–1483.
25. Bittar MN, Carey JA, Barnard JB, et al. Tumor necrosis factor alpha influences the inflammatory response after coronary surgery. Ann Thorac Surg. 2006; 81(1):132–138.
26. Tomasdottir H, Hjartarson H, Ricksten A, Wasslavik C, Bengtsson A, Ricksten SE. Tumor necrosis factor gene polymorphism is associated with enhanced systemic inflammatory response and increased cardiopulmonary morbidity after cardiac surgery. Anesth Analg. 2003; 97(4):944–949.
27. Kozik DJ, Tweddell JS. Characterizing the inflammatory response to cardiopulmonary bypass in children. Ann Thorac Surg. 2006; 81(6):S2347–S2354.
28. Fransen E, Maessen J, Dentener M, Senden N, Buurman W. Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery. Chest. 1999; 116(5):1233–1239.
29. Alcaraz AJ, Manzano L, Sancho L, et al. Different proinflammatory cytokine serum pattern in neonate patients undergoing open heart surgery. Relevance of IL-8. J Clin Immunol. 2005; 25(3):238–245.
30. Roth-Isigkeit A, Schwarzenberger J, Borstel T, et al. Perioperative cytokine release during coronary artery bypass grafting in patients of different ages. Clin Exp Immunol. 1998; 114(1):26–32.
31. Lequier LL, Nikaidoh H, Leonard SR, et al. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest. 2000; 117(6):1706–1712.
32. Polin RA, Pollack PF, Barlow B, et al. Necrotizing enterocolitis in term infants. J Pediatr. 1976; 89(3):460–462.
33. Martinez-Tallo E, Claure N, Bancalari E. Necrotizing enterocolitis in full-term or near-term infants: risk factors. Biol Neonate. 1997; 71(5):292–298.
34. Mou S, Haudek S, Lequier L. Myocardial inflammatory activation in children with congenital heart disease. Crit Care Med. 2002; 30(4):827–832.
35. Lovell AT. Anaesthetic implications of grown-up congenital heart disease. Br J Anaesth. 2004; 93(1):129–139.